Approval · Notice of Compliance 24293 · 2020
MAVENCLAD: Notice of Compliance 24293
Issued September 25, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24293
- Date
- September 25, 2020
- Company
- Emd Serono A Division Of Emd Inc CanadaMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Quality update
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MAVENCLAD | Not yet assigned | — |
Medicinal ingredients
- CLADRIBINE 10 MG per TAB